WhatsApp
Facebook
Instagram
X (Twitter)
YouTube
LinkedIn

24/7 Customer Support

ameile almonertinib mesilate tablets 55mg 20tablets per box

Description

 Indication & Scope

Almonertinib Mesilate Tablets (AMeiLe®) is a third-generation EGFR tyrosine kinase inhibitor (EGFR-TKI). It selectively inhibits mutant EGFR (including T790M and sensitive mutations), blocks downstream tumor proliferation signaling pathways, suppresses tumor growth and induces tumor cell apoptosis.

  • Mechanism
    Inhibit mutant EGFR tyrosine kinase activity, block EGFR signal transduction pathway
  • Drug class
    Third-generation EGFR-TKI / Targeted Anti-tumor Drug
  • Clinical use
    EGFR mutation-positive non-small cell lung cancer (including T790M resistant mutation)
Specification
Generic Name Almonertinib Mesilate Tablets
Brand Name AMeiLe®
Ingredient Almonertinib Mesilate
Dosage Form Film-Coated Tablets
Package 55mg*10 tablets*2 sachets/box
Conditions Treated Locally advanced or metastatic non-small cell lung cancer (NSCLC) with EGFR T790M mutation positive after prior EGFR-TKI treatment;EGFR mutation-positive locally advanced/metastatic non-small cell lung cancer (first-line treatment);Adjuvant therapy for EGFR mutation-positive early-stage non-small cell lung cancer
Taboos Hypersensitivity to almonertinib mesilate or any excipients
Place of origin Jiangsu,China
Priscription Type Prescription Drug, Class B Medicare
Storage Conditions Sealed, store below 30℃
Manufacturer Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
Registration Authority National Medical Products Administration (NMPA)
Approval number H20200004
Date of Revision April 30, 2025
Shelf Life  36 months

How to use ?

Recommended Dose: 110mg orally once daily, swallow whole with water, do not chew or crush, can be taken with or without food

 

Time: Fixed daily oral administration at the same time

 

Interaction: Caution with CYP3A4 inhibitors and inducers; monitor QT interval and liver function

 

Side effects: Rash, pruritus, diarrhea, anemia, elevated liver enzymes, creatine kinase elevation, interstitial lung disease, QT interval prolongation

Important Notice

This product shall only be used for post-exposure rabies prophylaxis by professional medical staff. It must be applied combined with rabies vaccine and injected via wound infiltration plus intramuscular routes as specified. Do not administer intravenously or alter the dosage at will. Hypersensitivity monitoring is required throughout the whole injection process.

Packaging & Shipping

Packaging

Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.

Shipping Methods

Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.

Export Support

Certificate of Analysis

GMP Certificate

Commercial Invoice

Packing List & CPP

Cold Chain Logistics

Customs Documentation

Scientific and regulatory sources

1.WHO References
2.NMPA
3.FDA
4.EMA

FAQ

What to do if creatine kinase increases significantly?

Undergo medical examination and follow doctor’s advice for dose adjustment or suspension.

Does almonertinib cure lung cancer completely?

It controls tumor progression, not a radical cure.

Should breastfeeding women take almonertinib?

Breastfeeding should be discontinued during medication.

What is the function of almonertinib mesilate?

Inhibit mutant EGFR tyrosine kinase and block tumor growth signaling.

AMeiLe® | Almonertinib Mesilate Tablets | NSCLC | DengYueRX

INN: Almonertinib Mesilate
Indications: NSCLC (non-small cell lung cancer)
Dosage Form: Film-Coated Tablets
Strength: 55mg/Tablet

Original price was: $277.82.Current price is: $236.14.

Low MOQ

WHO-GMP

Worldwide Delivery

Compliance and Regulatory Documents

Related Products

Scroll to Top

Your Cart

Your Cart

Your Cart is Empty

Start Shopping
Continue Shopping
Payment Details
Sub Total $0.00